DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

49.46 0.35 (0.71%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMY $49.46 0.71%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $49.04
Previous Close $49.11
Daily Range $48.95 - $49.68
52-Week Range $39.18 - $57.49
Market Cap $81.6B
P/E Ratio 32.12
Dividend (Yield) $1.44 (2.9%)
Ex-Dividend Date
Dividend Pay Date
04/02/14
05/01/14
Volume 6,670,783
Average Daily Volume 8,857,382
Current FY EPS $1.76

Sector

Healthcare

Industry

Drugs

Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website: http://www.bms.com/

News & Commentary

ARIAD Pharmaceuticals, Inc. Battling Back

Since returning to market, ARIAD Pharmaceuticals has captured about half of the patients on Iclusig before it went off the market, but it'll have a hard time competing with Novartis' and Bristol-Myers Squibb's leukemia drugs.

3 Stocks Reiterated As A Buy: BMY, CELG, V

Bristol-Myers Seeks Approval for HIV Combo Drug - Analyst Blog

Portola's Betrixaban Study Design Published - Analyst Blog

Noteworthy ETF Inflows: XLV, JNJ, AMGN, BMY

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog

Positive Data on AbbVie's HCV Program - Analyst Blog

Positive Data on AbbVie's HCV Program - Analyst Blog

UPDATE: Bristol-Myers Squibb Submits NDA to US FDA for Fixed-Dose Combo Tablet for Atazanavir Sulfat

UPDATE: Bristol-Myers Squibb Submits NDA to US FDA for Fixed-Dose Combo Tablet for Atazanavir Sulfate with Cobicistate

3 Stocks Reiterated As A Buy: BMY, LOW, CSCO

Encouraging Data from Bristol-Myers - Analyst Blog

Market Hustle: Stock Futures Flat Ahead of JPMorgan, Wells Fargo Earnings

See More BMY News...

BMY's Top Competitors

BMY $49.46 (0.71%)
Current stock: BMY
NVS $84.67 (0.31%)
Current stock: NVS
RHHBY $36.22 (0.14%)
Current stock: RHHBY
PFE $30.25 (0.53%)
Current stock: PFE